EE512 Fluticasone Furoate/Umeclidinium/Vilanterol Vs Open Triple Therapy for Treating Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD) from a Brazilian Public Healthcare Perspective: A Budget Impact Analysis
Abstract
Authors
M Araujo G Bernardino SY Tanaka